JP6121717B2 - 安定なヒアルロナン／ステロイド配合物 - Google Patents

安定なヒアルロナン／ステロイド配合物 Download PDF

Info

Publication number
JP6121717B2
JP6121717B2 JP2012528801A JP2012528801A JP6121717B2 JP 6121717 B2 JP6121717 B2 JP 6121717B2 JP 2012528801 A JP2012528801 A JP 2012528801A JP 2012528801 A JP2012528801 A JP 2012528801A JP 6121717 B2 JP6121717 B2 JP 6121717B2
Authority
JP
Japan
Prior art keywords
composition
hyaluronic acid
related component
component
change
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2012528801A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013504570A (ja
Inventor
チャン、グレース
ボスチン、エリザベス
ユ、リ−ピン
シュクラブット、ユージン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of JP2013504570A publication Critical patent/JP2013504570A/ja
Application granted granted Critical
Publication of JP6121717B2 publication Critical patent/JP6121717B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP2012528801A 2009-09-10 2010-08-10 安定なヒアルロナン／ステロイド配合物 Active JP6121717B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/556,869 US8273725B2 (en) 2009-09-10 2009-09-10 Stable hyaluronan/steroid formulation
US12/556,869 2009-09-10
PCT/US2010/044975 WO2011031402A1 (en) 2009-09-10 2010-08-10 Stable hyaluronan/steroid formulation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015138590A Division JP2015172095A (ja) 2009-09-10 2015-07-10 安定なヒアルロナン／ステロイド配合物

Publications (2)

Publication Number Publication Date
JP2013504570A JP2013504570A (ja) 2013-02-07
JP6121717B2 true JP6121717B2 (ja) 2017-04-26

Family

ID=43648224

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012528801A Active JP6121717B2 (ja) 2009-09-10 2010-08-10 安定なヒアルロナン／ステロイド配合物
JP2015138590A Pending JP2015172095A (ja) 2009-09-10 2015-07-10 安定なヒアルロナン／ステロイド配合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015138590A Pending JP2015172095A (ja) 2009-09-10 2015-07-10 安定なヒアルロナン／ステロイド配合物

Country Status (8)

Country Link
US (2) US8273725B2 (cg-RX-API-DMAC7.html)
EP (2) EP3622820A1 (cg-RX-API-DMAC7.html)
JP (2) JP6121717B2 (cg-RX-API-DMAC7.html)
CN (1) CN102573468B (cg-RX-API-DMAC7.html)
AR (1) AR078281A1 (cg-RX-API-DMAC7.html)
BR (1) BR112012005423B1 (cg-RX-API-DMAC7.html)
MX (1) MX2012002830A (cg-RX-API-DMAC7.html)
WO (1) WO2011031402A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
MX2012001204A (es) 2009-07-30 2012-08-03 Carbylan Biosurgery Inc Composiciones de polimero de acido hialuronico modificado y metodos relacionados.
CN103732264B (zh) 2011-04-20 2017-07-14 卡比兰治疗公司 原位凝胶形成组合物
TWI424007B (zh) 2011-12-22 2014-01-21 Ind Tech Res Inst 使膠體交聯的方法與藉由此方法形成之經交聯的膠體
WO2014110454A1 (en) * 2013-01-11 2014-07-17 Carbylan Biosurgery, Inc. Stabilized compositions comprising hyaluronic acid
IT201600075246A1 (it) 2016-07-19 2018-01-19 Jointherapeutics S R L Composizioni comprendenti una matrice polisaccaridica per il rilascio controllato di principi attivi.
CN106983733A (zh) * 2017-03-08 2017-07-28 江苏富泽药业有限公司 曲安奈德plga缓释微球注射剂、其制备方法及其在制备治疗骨关节炎疼痛药物中的应用
KR20190038368A (ko) 2017-09-29 2019-04-08 주식회사 엘지화학 히알루론산 기반 하이드로겔 약제학적 안정화 조성물 및 그 제조방법
CN118021719A (zh) * 2022-11-11 2024-05-14 北京华视诺维医疗科技有限公司 一种曲安奈德组合物及其制备方法
WO2025068242A1 (en) * 2023-09-25 2025-04-03 Hyamedix Dexamethasone delivery system

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
SE442820B (sv) 1984-06-08 1986-02-03 Pharmacia Ab Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut
US4582865A (en) 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
SE8501022L (sv) 1985-03-01 1986-09-02 Pharmacia Ab Format alster och forfarande for dess framstellning
US4713448A (en) 1985-03-12 1987-12-15 Biomatrix, Inc. Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues
US4851521A (en) * 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
US5356883A (en) * 1989-08-01 1994-10-18 Research Foundation Of State University Of N.Y. Water-insoluble derivatives of hyaluronic acid and their methods of preparation and use
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
US5143724A (en) 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5207983A (en) * 1992-01-29 1993-05-04 Sterling Winthrop Inc. Method of terminal steam sterilization
IT1260154B (it) * 1992-07-03 1996-03-28 Lanfranco Callegaro Acido ialuronico e suoi derivati in polimeri interpenetranti (ipn)
US5616568A (en) * 1993-11-30 1997-04-01 The Research Foundation Of State University Of New York Functionalized derivatives of hyaluronic acid
US5621093A (en) * 1995-06-06 1997-04-15 Anika Research, Inc. Steam-sterilizing solid hyaluronic acid
US5827937A (en) 1995-07-17 1998-10-27 Q Med Ab Polysaccharide gel composition
TW577758B (en) * 1997-10-27 2004-03-01 Ssp Co Ltd Intra-articular preparation for the treatment of arthropathy
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6066292A (en) * 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
US6521223B1 (en) * 2000-02-14 2003-02-18 Genzyme Corporation Single phase gels for the prevention of adhesions
US6726918B1 (en) * 2000-07-05 2004-04-27 Oculex Pharmaceuticals, Inc. Methods for treating inflammation-mediated conditions of the eye
WO2002009792A1 (en) 2000-07-28 2002-02-07 Anika Therapeutics, Inc. Bioabsorbable composites of derivatized hyaluronic acid
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
DK1337279T3 (da) * 2000-11-24 2006-09-25 Breath Ltd Sterilisation af glucocorticosteroidsuspensioner
WO2003002159A1 (en) * 2001-06-29 2003-01-09 Biovitrum Ab Process for bulk autoclaving
AU2003230948A1 (en) 2002-04-17 2003-11-03 Genzyme Corporation Cross-linked hyaluronate compounds
US20070224278A1 (en) * 2003-11-12 2007-09-27 Lyons Robert T Low immunogenicity corticosteroid compositions
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20050142152A1 (en) 2003-12-30 2005-06-30 Leshchiner Adelya K. Polymeric materials, their preparation and use
EP2754454A3 (en) 2004-01-07 2014-09-24 Seikagaku Corporation Non-steroidal anti-inflammatory drug derivatives
US20060094700A1 (en) * 2004-11-02 2006-05-04 Allergan, Inc. Heat sterilization of a steroid in the presence of phosphate
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
WO2008098019A2 (en) * 2007-02-05 2008-08-14 Carbylan Biosurgery, Inc. Polymer formulations for delivery of bioactive agents
FR2918276B1 (fr) 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
US20090143348A1 (en) * 2007-11-30 2009-06-04 Ahmet Tezel Polysaccharide gel compositions and methods for sustained delivery of drugs
JP2011510971A (ja) 2008-01-31 2011-04-07 ソフラディム・プロデュクスィヨン 中性ｐＨで可溶性の終末的に滅菌されたコラーゲンの製造

Also Published As

Publication number Publication date
US20110059918A1 (en) 2011-03-10
US8680073B2 (en) 2014-03-25
WO2011031402A1 (en) 2011-03-17
US20120316131A1 (en) 2012-12-13
CN102573468B (zh) 2015-05-20
US8273725B2 (en) 2012-09-25
AR078281A1 (es) 2011-10-26
EP2475251B1 (en) 2019-07-17
EP3622820A1 (en) 2020-03-18
BR112012005423A2 (pt) 2017-07-04
JP2015172095A (ja) 2015-10-01
MX2012002830A (es) 2012-04-10
EP2475251A1 (en) 2012-07-18
BR112012005423B1 (pt) 2022-09-13
CN102573468A (zh) 2012-07-11
JP2013504570A (ja) 2013-02-07
EP2475251A4 (en) 2012-10-24

Similar Documents

Publication Publication Date Title
JP6121717B2 (ja) 安定なヒアルロナン／ステロイド配合物
JP6660469B2 (ja) ヒアルロン酸誘導体およびｄｎａ分画物が含まれているヒアルロン酸注射用組成物およびその利用
CN108136070B (zh) 创伤后骨关节炎的预防性治疗
Madan et al. In situ forming polymeric drug delivery systems
Ågerup et al. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis
CN104027348B (zh) 用于治疗关节的组合物和方法
JP6759220B2 (ja) 関節脂肪パッド製剤、およびその使用方法
BRPI0909630B1 (pt) Composição em suspensão aquosa particularmente adequada para injeção dentro do olho
BR112019004332B1 (pt) Géis injetáveis que compreendem ácido hialurônico reticulado e hidroxiapatita, composição e processo de fabricação dos mesmos
JP2015526537A (ja) ヒアルロン酸に基づく組成物の調製方法
CN104220078A (zh) 包括硫酸软骨素和透明质酸衍生物的药物制剂
KR20160096205A (ko) 메피바카인을 포함하는 히알루론산 조성물
CN113877000B (zh) 注射用微球组合物及其应用
CN1859918B (zh) 透明质酸在制备治疗急性和过劳扭伤、拉伤的药物中的应用
KR20070094608A (ko) 삼원 천연중합체 점탄성 조성물
KR20200008560A (ko) 수성 히알루론산 겔의 제조 방법
CN116370707A (zh) 一种注射填充剂及其制备方法
TW201739457A (zh) 組成物在製備治療動物或人的受傷肌腱之藥物的用途與套組
HK40025754A (en) Stable hyaluronan/steroid formulation
HK1168732A (en) Stable hyaluronan/steroid formulation
HK1168732B (en) Stable hyaluronan/steroid formulation
CN112584868A (zh) 有助于软组织增大/增强的协同合作组合物、药物递送及相关领域
TR202022151A2 (tr) Enjekte edi̇lebi̇li̇r fotoçapraz bağli hi̇yaluroni̇k asi̇t hi̇drojeller, bunlarin üreti̇m yöntemi̇ ve osteoartri̇t tedavi̇si̇ i̇çi̇n kullanimi
CN120695028A (zh) 一种丁甘交联透明质酸钠凝胶及其组合物和制备方法
TW201914593A (zh) 經藥學上穩定化之基於玻尿酸的水凝膠組成物及其製備方法

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130809

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141029

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150310

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150710

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20150901

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20151106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20161005

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170330

R150 Certificate of patent or registration of utility model

Ref document number: 6121717

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250